inositol has been researched along with Abnormalities, Drug-Induced in 5 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Valproic acid (VPA) is an anticonvulsant drug that is widely used therapeutically for a variety of neurological conditions." | 1.33 | Myo-inositol enhances teratogenicity of valproic acid in the mouse. ( Finnell, RH; Giavini, E; Massa, V; Wlodarczyk, B, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Massa, V | 1 |
| Wlodarczyk, B | 1 |
| Giavini, E | 1 |
| Finnell, RH | 1 |
| Sconzo, G | 1 |
| Cascino, D | 1 |
| Amore, G | 1 |
| Geraci, F | 1 |
| Giudice, G | 1 |
| Wentzel, P | 1 |
| Wentzel, CR | 1 |
| Gäreskog, MB | 1 |
| Eriksson, UJ | 1 |
| Busa, WB | 1 |
| Gimlich, RL | 1 |
| Linari, G | 1 |
5 other studies available for inositol and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Myo-inositol enhances teratogenicity of valproic acid in the mouse.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anticonvulsants; Drug Synergism; Embryo | 2006 |
Effect of the IMPase inhibitor L690,330 on sea urchin development.
Topics: 5'-Nucleotidase; Abnormalities, Drug-Induced; Animals; Calcium-Calmodulin-Dependent Protein Kinases; | 1998 |
Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity.
Topics: Abnormalities, Drug-Induced; Acetylcysteine; Animals; Diabetes Mellitus, Experimental; Dose-Response | 2001 |
Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog.
Topics: Abnormalities, Drug-Induced; Animals; Blastomeres; Central Nervous System; Diglycerides; Exocrine Gl | 1989 |
Observations on the synthesis, chemical hydrolysis in vitro and toxicity of a new ester of nicotinic acid: the mesoinosito pentanicotinate.
Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; Blood; Body Weight; Chemistry, Pharmaceutica | 1970 |